Use of antibiotic-loaded cement in total knee arthroplasty

World Journal of Orthopedics

Volumn 6, Issue 11, 2015, Pages 877-885

  Hinarejos, Pedro ^a   Guirro, Pau ^a   Puig Verdie, Lluis ^a   Torres Claramunt, Raul ^a   Leal Blanquet, Joan ^a   Sanchez Soler, Juan ^a   Monllau, Joan Carles ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Antibiotic loaded cement; Antibiotic toxicity; Antimicrobial resistance; Economic cost; Infection; Prophylaxis; Total knee arthroplasty

Indexed keywords

EID: 84952304355     PISSN: None     EISSN: 22185836     Source Type: Journal    
DOI: 10.5312/wjo.v6.i11.877     Document Type: Review

References (82)

1. Gristina AG, Costerton JW. Bacterial adherence to biomaterials and tissue. The significance of its role in clinical sepsis. J Bone Joint Surg Am 1985; 67: 264-273 [PMID: 3881449]
2. van de Belt H, Neut D, Schenk W, van Horn JR, van Der Mei HC, Busscher HJ. Staphylococcus aureus biofilm formation on different gentamicin-loaded polymethylmethacrylate bone cements. Biomaterials 2001; 22: 1607-1611 [PMID: 11374461]
3. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004; 351: 1645-1654 [PMID: 15483283 DOI: 10.1056/NEJMra040181]
4. Robertsson O, Knutson K, Lewold S, Lidgren L. The Swedish Knee Arthroplasty Register 1975-1997: an update with special emphasis on 41, 223 knees operated on in 1988-1997. Acta Orthop Scand 2001; 72: 503-513 [PMID: 11728079 DOI: 10.1080/0001647 01753532853]
5. Garvin KL, Konigsberg BS. Infection following total knee arthroplasty: prevention and management. J Bone Joint Surg Am 2011; 93: 1167-1175 [PMID: 21776555]
6. Kurtz SM, Ong KL, Lau E, Bozic KJ, Berry D, Parvizi J. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res 2010; 468: 52-56 [PMID: 19669386 DOI: 10.1007/s11999-009-1013-5]
7. Hansen EN, Adeli B, Kenyon R, Parvizi J. Routine use of antibiotic laden bone cement for primary total knee arthroplasty: impact on infecting microbial patterns and resistance profiles. J Arthroplasty 2014; 29: 1123-1127 [PMID: 24418770 DOI: 10.1016/j.arth.2013.12.004]
8. Srivastav AK, Nadkarni B, Srivastav S, Mittal V, Agarwal S. Prophylactic use of antibiotic-loaded bone cement in primary total knee arthroplasty: Justified or not? Indian J Orthop 2009; 43: 259-263 [PMID: 19838348 DOI: 10.4103/0019-5413.53456]
9. Chiang CC, Chiu FY. Cefuroxime-impregnated cement and systemic cefazolin for 1 week in primary total knee arthroplasty: an evaluation of 2700 knees. J Chin Med Assoc 2012; 75: 167-170 [PMID: 22541145 DOI: 10.1016/j.jcma.2012.02.016]
10. Qadir R, Sidhu S, Ochsner JL, Meyer MS, Chimento GF. Risk stratified usage of antibiotic-loaded bone cement for primary total knee arthroplasty: short term infection outcomes with a standardized cement protocol. J Arthroplasty 2014; 29: 1622-1624 [PMID: 24703363 DOI: 10.1016/j.arth.2014.02.032]
11. Buchholz HW, Engelbrecht H. [Depot effects of various antibiotics mixed with Palacos resins]. Chirurg 1970; 41: 511-515 [PMID: 5487941]
12. Carlsson AS, Josefsson G, Lindberg L. Revision with gentamicinimpregnated cement for deep infections in total hip arthroplasties. J Bone Joint Surg Am 1978; 60: 1059-1064 [PMID: 721853]
13. Hanssen AD. Prophylactic use of antibiotic bone cement: an emerging standard-in opposition. J Arthroplasty 2004; 19: 73-77 [PMID: 15190554]
14. Jämsen E, Huhtala H, Puolakka T, Moilanen T. Risk factors for infection after knee arthroplasty. A register-based analysis of 43, 149 cases. J Bone Joint Surg Am 2009; 91: 38-47 [PMID: 19122077 DOI: 10.2106/JBJS.G.01686]
15. Ueng SW, Hsieh PH, Shih HN, Chan YS, Lee MS, Chang Y. Antibacterial activity of joint fluid in cemented total-knee arthroplasty: an in vivo comparative study of polymethylmethacrylate with and without antibiotic loading. Antimicrob Agents Chemother 2012; 56: 5541-5546 [PMID: 22890771 DOI: 10.1128/AAC.01067-12]
16. Malik MH, Chougle A, Pradhan N, Gambhir AK, Porter ML. Primary total knee replacement: a comparison of a nationally agreed guide to best practice and current surgical technique as determined by the North West Regional Arthroplasty Register. Ann R Coll Surg Engl 2005; 87: 117-122 [PMID: 15826423 DOI: 10.1308/1478708051676]
17. Espehaug B, Furnes O, Havelin LI, Engesaeter LB, Vollset SE. The type of cement and failure of total hip replacements. J Bone Joint Surg Br 2002; 84: 832-838 [PMID: 12211673]
18. Engesaeter LB, Espehaug B, Lie SA, Furnes O, Havelin LI. Does cement increase the risk of infection in primary total hip arthroplasty? Revision rates in 56, 275 cemented and uncemented primary THAs followed for 0-16 years in the Norwegian Arthroplasty Register. Acta Orthop 2006; 77: 351-358 [PMID: 16819671]
19. Heck D, Rosenberg A, Schink-Ascani M, Garbus S, Kiewitt T. Use of antibiotic-impregnated cement during hip and knee arthroplasty in the United States. J Arthroplasty 1995; 10: 470-475 [PMID: 8523006]
20. Fish DN, Hoffman HM, Danziger LH. Antibiotic-impregnated cement use in U.S. hospitals. Am J Hosp Pharm 1992; 49: 2469-2474 [PMID: 1442824]
21. Gandhi R, Razak F, Pathy R, Davey JR, Syed K, Mahomed NN. Antibiotic bone cement and the incidence of deep infection after total knee arthroplasty. J Arthroplasty 2009; 24: 1015-1018 [PMID: 18823748 DOI: 10.1016/j.arth.2008.08.004]
22. Jiranek WA, Hanssen AD, Greenwald AS. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J Bone Joint Surg Am 2006; 88: 2487-2500 [PMID: 17079409 DOI: 10.2106/JBJS.E.01126]
23. Randelli P, Evola FR, Cabitza P, Polli L, Denti M, Vaienti L. Prophylactic use of antibiotic-loaded bone cement in primary total knee replacement. Knee Surg Sports Traumatol Arthrosc 2010; 18: 181-186 [PMID: 19795106 DOI: 10.1007/s00167-009-0921-y]
24. Australian Orthopaedic Association. University of Adelaide. National Joint Replacement Registry. Cement in Hip & Knee Arthroplasty. Supplementary Report 2014. [accessed 2015 May 27]. Available from: URL: https://aoanjrr.dmac.adelaide.edu.au/documents/10180/172288/CementinHip&KneeArthroplasty
25. Dale H, Hallan G, Hallan G, Espehaug B, Havelin LI, Engesaeter LB. Increasing risk of revision due to deep infection after hip arthroplasty. Acta Orthop 2009; 80: 639-645 [PMID: 19995313 DOI: 10.3109/17453670903506658]
26. Chiu FY, Chen CM, Lin CF, Lo WH. Cefuroxime-impregnated cement in primary total knee arthroplasty: a prospective, randomized study of three hundred and forty knees. J Bone Joint Surg Am 2002; 84-A: 759-762 [PMID: 12004017]
27. Holm NJ, Vejlsgaard R. The in vitro elution of gentamicin sulphate from methylmethacrylate bone cement. A comparative study. Acta Orthop Scand 1976; 47: 144-148 [PMID: 1274536]
28. Cerretani D, Giorgi G, Fornara P, Bocchi L, Neri L, Ceffa R, Ghisellini F, Ritter MA. The in vitro elution characteristics of vancomycin combined with imipenem-cilastatin in acrylic bonecements: a pharmacokinetic study. J Arthroplasty 2002; 17: 619-626 [PMID: 12168180]
29. Ruzaimi MY, Shahril Y, Masbah O, Salasawati H. Antimicrobial properties of erythromycin and colistin impregnated bone cement. An in vitro analysis. Med J Malaysia 2006; 61 Suppl A: 21-26 [PMID: 17042224]
30. Hendriks JG, Neut D, van Horn JR, van der Mei HC, Busscher HJ. Bacterial survival in the interfacial gap in gentamicin-loaded acrylic bone cements. J Bone Joint Surg Br 2005; 87: 272-276 [PMID: 15736756]
31. Klekamp J, Dawson JM, Haas DW, DeBoer D, Christie M. The use of vancomycin and tobramycin in acrylic bone cement: biomechanical effects and elution kinetics for use in joint arthroplasty. J Arthroplasty 1999; 14: 339-346 [PMID: 10220189]
32. Powles JW, Spencer RF, Lovering AM. Gentamicin release from old cement during revision hip arthroplasty. J Bone Joint Surg Br 1998; 80: 607-610 [PMID: 9699820]
33. Dunne NJ, Hill J, McAfee P, Kirkpatrick R, Patrick S, Tunney M. Incorporation of large amounts of gentamicin sulphate into acrylic bone cement: effect on handling and mechanical properties, antibiotic release, and biofilm formation. Proc Inst Mech Eng H 2008; 222: 355-365 [PMID: 18491704]
34. Chang YH, Tai CL, Hsu HY, Hsieh PH, Lee MS, Ueng SW. Liquid antibiotics in bone cement: an effective way to improve the efficiency of antibiotic release in antibiotic loaded bone cement. Bone Joint Res 2014; 3: 246-251 [PMID: 25104836 DOI: 10.1302/2046-3758.38.2000305]
35. Neut D, van de Belt H, van Horn JR, van der Mei HC, Busscher HJ. The effect of mixing on gentamicin release from polymethylmethacrylate bone cements. Acta Orthop Scand 2003; 74: 670-676 [PMID: 14763697 DOI: 10.1080/00016470310018180]
36. Chen AF, Parvizi J. Antibiotic-loaded bone cement and periprosthetic joint infection. J Long Term Eff Med Implants 2014; 24: 89-97 [PMID: 25272207]
37. Scott CP, Higham PA, Dumbleton JH. Effectiveness of bone cement containing tobramycin. An in vitro susceptibility study of 99 organisms found in infected joint arthroplasty. J Bone Joint Surg Br 1999; 81: 440-443 [PMID: 10872362]
38. Chang Y, Tai CL, Hsieh PH, Ueng SW. Gentamicin in bone cement: A potentially more effective prophylactic measure of infectionin joint arthroplasty. Bone Joint Res 2013; 2: 220-226 [PMID: 24128666 DOI: 10.1302/2046-3758.210.2000188]
39. Penner MJ, Masri BA, Duncan CP. Elution characteristics of vancomycin and tobramycin combined in acrylic bone-cement. J Arthroplasty 1996; 11: 939-944 [PMID: 8986572]
40. Espehaug B, Engesaeter LB, Vollset SE, Havelin LI, Langeland N. Antibiotic prophylaxis in total hip arthroplasty. Review of 10, 905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995. J Bone Joint Surg Br 1997; 79: 590-595 [PMID: 9250744]
41. Josefsson G, Gudmundsson G, Kolmert L, Wijkström S. Prophylaxis with systemic antibiotics versus gentamicin bone cement in total hip arthroplasty. A five-year survey of 1688 hips. Clin Orthop Relat Res 1990; (253): 173-178 [PMID: 2107994]
42. Josefsson G, Kolmert L. Prophylaxis with systematic antibiotics versus gentamicin bone cement in total hip arthroplasty. A ten-year survey of 1, 688 hips. Clin Orthop Relat Res 1993; (292): 210-214 [PMID: 8519111]
43. Bohm E, Zhu N, Gu J, de Guia N, Linton C, Anderson T, Paton D, Dunbar M. Does adding antibiotics to cement reduce the need for early revision in total knee arthroplasty? Clin Orthop Relat Res 2014; 472: 162-168 [PMID: 23884803 DOI: 10.1007/s11999-013-3 186-1]
44. Chiu FY, Lin CF, Chen CM, Lo WH, Chaung TY. Cefuroximeimpregnated cement at primary total knee arthroplasty in diabetes mellitus. A prospective, randomised study. J Bone Joint Surg Br 2001; 83: 691-695 [PMID: 11476307]
45. Liu HT, Chiu FY, Chen CM, Chen TH. The combination of systemic antibiotics and antibiotics impregnated cement in primary total knee arthroplasty in patients of rheumatoid arthritis-evaluation of 60 knees. J Chin Med Assoc 2003; 66: 533-536 [PMID: 14649677]
46. Namba RS, Chen Y, Paxton EW, Slipchenko T, Fithian DC. Outcomes of routine use of antibiotic-loaded cement in primary total knee arthroplasty. J Arthroplasty 2009; 24: 44-47 [PMID: 19577881 DOI: 10.1016/j.arth.2009.05.007]
47. Hinarejos P, Guirro P, Leal J, Montserrat F, Pelfort X, Sorli ML, Horcajada JP, Puig L. The use of erythromycin and colistin-loaded cement in total knee arthroplasty does not reduce the incidence of infection: a prospective randomized study in 3000 knees. J Bone Joint Surg Am 2013; 95: 769-774 [PMID: 23636182 DOI: 10.2106/JBJS.L.00901]
48. Parvizi J, Saleh KJ, Ragland PS, Pour AE, Mont MA. Efficacy of antibiotic-impregnated cement in total hip replacement. Acta Orthop 2008; 79: 335-341 [PMID: 18622836 DOI: 10.1080/174536 70710015229]
49. Wang J, Zhu C, Cheng T, Peng X, Zhang W, Qin H, Zhang X. A systematic review and meta-analysis of antibiotic-impregnated bone cement use in primary total hip or knee arthroplasty. PLoS One 2013; 8: e82745 [PMID: 24349353 DOI: 10.1371/journal. pone.0082745]
50. Zhou Y, Li L, Zhou Q, Yuan S, Wu Y, Zhao H, Wu H. Lack of efficacy of prophylactic application of antibiotic-loaded bone cement for prevention of infection in primary total knee arthroplasty: results of a meta-analysis. Surg Infect (Larchmt) 2015; 16: 183-187 [PMID: 25826289 DOI: 10.1089/sur.2014.044]
51. Lautenschlager EP, Jacobs JJ, Marshall GW, Meyer PR. Mechanical properties of bone cements containing large doses of antibiotic powders. J Biomed Mater Res 1976; 10: 929-938 [PMID: 993228 DOI: 10.1002/jbm.820100610]
52. Bistolfi A, Massazza G, Verné E, Massè A, Deledda D, Ferraris S, Miola M, Galetto F, Crova M. Antibiotic-loaded cement in orthopedic surgery: a review. ISRN Orthop 2011; 2011: 290851 [PMID: 24977058 DOI: 10.5402/2011/290851]
53. Seldes RM, Winiarsky R, Jordan LC, Baldini T, Brause B, Zodda F, Sculco TP. Liquid gentamicin in bone cement: a laboratory study of a potentially more cost-effective cement spacer. J Bone Joint Surg Am 2005; 87: 268-272 [PMID: 15687146 DOI: 10.2106/JBJS. C.00728]
54. Postak PD, Greenwald AS. The influence of antibiotics on the fatigue life of acrylic bone cement. J Bone Joint Surg Am 2006; 88 Suppl 4: 148-155 [PMID: 17142444 DOI: 10.2106/JBJS.F.00586]
55. Bohm E, Petrak M, Gascoyne T, Turgeon T. The effect of adding tobramycin to Simplex P cement on femoral stem micromotion as measured by radiostereometric analysis: a 2-year randomized controlled trial. Acta Orthop 2012; 83: 115-120 [PMID: 22248163 DOI: 10.3109/17453674.2011.652885]
56. Adalberth G, Nilsson KG, Kärrholm J, Hassander H. Fixation of the tibial component using CMW-1 or Palacos bone cement with gentamicin: similar outcome in a randomized radiostereometric study of 51 total knee arthroplasties. Acta Orthop Scand 2002; 73: 531-538 [PMID: 12440496 DOI: 10.1080/000164702321022802]
57. Ince A, Schütze N, Karl N, Löhr JF, Eulert J. Gentamicin negatively influenced osteogenic function in vitro. Int Orthop 2007; 31: 223-228 [PMID: 16710734 DOI: 10.1007/s00264-006-0144-5]
58. Edin ML, Miclau T, Lester GE, Lindsey RW, Dahners LE. Effect of cefazolin and vancomycin on osteoblasts in vitro. Clin Orthop Relat Res 1996; (333): 245-251 [PMID: 8981903]
59. Kalil GZ, Ernst EJ, Johnson SJ, Johannsson B, Polgreen PM, Bertolatus JA, Clark CR. Systemic exposure to aminoglycosides following knee and hip arthroplasty with aminoglycoside-loaded bone cement implants. Ann Pharmacother 2012; 46: 929-934 [PMID: 22764326 DOI: 10.1345/aph.1R049]
60. Springer BD, Lee GC, Osmon D, Haidukewych GJ, Hanssen AD, Jacofsky DJ. Systemic safety of high-dose antibiotic-loaded cement spacers after resection of an infected total knee arthroplasty. Clin Orthop Relat Res 2004; (427): 47-51 [PMID: 15552135]
61. Patrick BN, Rivey MP, Allington DR. Acute renal failure associated with vancomycin-and tobramycin-laden cement in total hip arthroplasty. Ann Pharmacother 2006; 40: 2037-2042 [PMID: 17032907 DOI: 10.1345/aph.1H173]
62. Curtis JM, Sternhagen V, Batts D. Acute renal failure after placement of tobramycin-impregnated bone cement in an infected total knee arthroplasty. Pharmacotherapy 2005; 25: 876-880 [PMID: 15927906]
63. van Raaij TM, Visser LE, Vulto AG, Verhaar JA. Acute renal failure after local gentamicin treatment in an infected total knee arthroplasty. J Arthroplasty 2002; 17: 948-950 [PMID: 12375257]
64. Dovas S, Liakopoulos V, Papatheodorou L, Chronopoulou I, Papavasiliou V, Atmatzidis E, Giannopoulou M, Eleftheriadis T, Simopoulou T, Karachalios T, Stefanidis I. Acute renal failure after antibiotic-impregnated bone cement treatment of an infected total knee arthroplasty. Clin Nephrol 2008; 69: 207-212 [PMID: 18397720]
65. Mounasamy V, Fulco P, Desai P, Adelaar R, Bearman G. The successful use of vancomycin-impregnated cement beads in a patient with vancomycin systemic toxicity: a case report with review of literature. Eur J Orthop Surg Traumatol 2013; 23 Suppl 2: S299-S302 [PMID: 23412194 DOI: 10.1007/s00590-012-1062-4]
66. Forsythe ME, Crawford S, Sterling GJ, Whitehouse SL, Crawford R. Safeness of Simplex-tobramycin bone cement in patients with renal dysfunction undergoing total hip replacement. J Orthop Surg (Hong Kong) 2006; 14: 38-42 [PMID: 16598085]
67. Dunbar MJ. Antibiotic bone cements: their use in routine primary total joint arthroplasty is justified. Orthopedics 2009; 32 [PMID: 19751021]
68. Cummins JS, Tomek IM, Kantor SR, Furnes O, Engesaeter LB, Finlayson SR. Cost-effectiveness of antibiotic-impregnated bone cement used in primary total hip arthroplasty. J Bone Joint Surg Am 2009; 91: 634-641 [PMID: 19255224 DOI: 10.2106/JBJS.G.01029]
69. Williams B, Hanson A, Sha B. Diffuse Desquamating Rash Following Exposure to Vancomycin-Impregnated Bone Cement. Ann Pharmacother 2014; 48: 1061-1065 [PMID: 24740467 DOI: 10.1177/1060028014529547]
70. Neut D, van de Belt H, Stokroos I, van Horn JR, van der Mei HC, Busscher HJ. Biomaterial-associated infection of gentamicinloaded PMMA beads in orthopaedic revision surgery. J Antimicrob Chemother 2001; 47: 885-891 [PMID: 11389124]
71. Corona PS, Espinal L, Rodríguez-Pardo D, Pigrau C, Larrosa N, Flores X. Antibiotic susceptibility in gram-positive chronic joint arthroplasty infections: increased aminoglycoside resistance rate in patients with prior aminoglycoside-impregnated cement spacer use. J Arthroplasty 2014; 29: 1617-1621 [PMID: 24798194 DOI: 10.1016/j.arth.2014.03.029]
72. Fletcher MD, Spencer RF, Langkamer VG, Lovering AM. Gentamicin concentrations in diagnostic aspirates from 25 patients with hip and knee arthroplasties. Acta Orthop Scand 2004; 75: 173-176 [PMID: 15180232 DOI: 10.1080/00016470412331294425]
73. Gutowski CJ, Zmistowski BM, Clyde CT, Parvizi J. The economics of using prophylactic antibiotic-loaded bone cement in total knee replacement. Bone Joint J 2014; 96-B: 65-69 [PMID: 24395313 DOI: 10.1302/0301-620X.96B1.31428]
74. Lavernia C, Lee DJ, Hernandez VH. The increasing financial burden of knee revision surgery in the United States. Clin Orthop Relat Res 2006; 446: 221-226 [PMID: 16672891 DOI: 10.1097/01. blo.0000214424.67453.9a]
75. Engesaeter LB, Lie SA, Espehaug B, Furnes O, Vollset SE, Havelin LI. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22, 170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 2003; 74: 644-651 [PMID: 14763692 DOI: 10.1080/000164703100 18135]
76. Malinzak RA, Ritter MA, Berend ME, Meding JB, Olberding EM, Davis KE. Morbidly obese, diabetic, younger, and unilateral joint arthroplasty patients have elevated total joint arthroplasty infection rates. J Arthroplasty 2009; 24: 84-88 [PMID: 19604665 DOI: 10.1016/j.arth.2009.05.016]
77. Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 2008; 466: 1710-1715 [PMID: 18421542 DOI: 10.1007/s11999-008-0209-4]
78. Dowsey MM, Choong PF. Obese diabetic patients are at substantial risk for deep infection after primary TKA. Clin Orthop Relat Res 2009; 467: 1577-1581 [PMID: 18841430 DOI: 10.1007/s11999-00 8-0551-6]
79. Jämsen E, Nevalainen P, Kalliovalkama J, Moilanen T. Preoperative hyperglycemia predicts infected total knee replacement. Eur J Intern Med 2010; 21: 196-201 [PMID: 20493422 DOI: 10.1016/j.ejim.2010.02.006]
80. Mraovic B, Suh D, Jacovides C, Parvizi J. Perioperative hyperglycemia and postoperative infection after lower limb arthroplasty. J Diabetes Sci Technol 2011; 5: 412-418 [PMID: 21527113 DOI: 10.1177/193229681100500231]
81. Namba RS, Inacio MC, Paxton EW. Risk factors associated with deep surgical site infections after primary total knee arthroplasty: an analysis of 56, 216 knees. J Bone Joint Surg Am 2013; 95: 775-782 [PMID: 23636183 DOI: 10.2106/JBJS.L.00211]
82. Willis-Owen CA, Konyves A, Martin DK. Factors affecting the incidence of infection in hip and knee replacement: an analysis of 5277 cases. J Bone Joint Surg Br 2010; 92: 1128-1133 [PMID: 20675759 DOI: 10.1302/0301-620X.92B8.24333]